The Drug Enforcement Administration today published a direct final rule to clarify that either the purchaser or the supplier may enter a supplier’s DEA registration number on the new single-sheet form that DEA registrants use to order schedule I and II controlled substances. DEA will accept comments on the rule through Aug. 19.

The rule takes effect Oct. 18 unless DEA receives significant adverse comments, in which case it would withdraw the rule by Sept. 20.  

Related News Articles

Headline
The Senate Special Committee on Aging held a hearing Feb. 11 on issues impacting physician burnout. The AHA provided a statement for the hearing and urged…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the…
Headline
Capitol Hill was the focus of the second morning of the AHA 2026 Rural Health Care Leadership Conference, taking place through tomorrow in…
Headline
The AHA Feb. 10 released its 2026 Rural Advocacy Agenda, laying out the association's key priorities for Congress, the administration, regulatory agencies and…
Headline
Carmela Coyle, California Hospital Association president and CEO, announced plans Feb. 5 to retire in early 2027, according to the CHA. Coyle has been in…
Headline
Update: The Senate passed the measure by a vote of 71-29.The Senate Jan. 30 is expected to pass a government funding plan ahead of a midnight deadline. A…